---
source_image: "legal-filing+affidavit+deposition-transcript+court-document__EFTA01381328_20260130_p001_i001.png"
source_pdf: "EFTA01381328.pdf"
method: pdf_text
words: 630
confidence: 1.00
extracted: 2026-02-13T17:06:38.645208
---

Form S-I 
Table of Contents 
Underwriting Discounts and Expenses 
The underwriting fee is equal to the public offering price per share of common stock less the amount paid by the underwriters to the 
selling stockholders per share of common stock. The underwriting fee is $ 
per share of common stock sold by the selling stockholders. No 
underwriting fee will be paid with respect to the shams to be issued by us to certain non-management employees. See "â€”The LOYAL3 Platform'.
below. The following table shows the per share and total underwriting discounts and commissions to be paid to the undeiwriters assuming both no 
exercise and full exercise of the underwriters' ova-allotment option to purchase additional shares. 
Paid by the selling stockholders 
Per Share 
Total 
Without exercise 
With full 
of over-allotment 
exercise of ov er-
uption to 
allotment option 
purchase 
to purchase 
additional shares 
additional shares 
We estimate that the total expenses of this offering, including registration, filing and listing fees, printing fees and legal and accounting 
expenses, but excluding the underwriting discounts and commissions, will be approximately S 
. We have agreed to reimburse the underwriters 
for certain expenses in an amount up to $ 
. 
A prospectus in electronic format may be made available on the web sites maintained by one or more underwriters, or selling group 
members. if any. participating in the offering. The underwriters may agree to allocate a number of shares to underwriters and selling group 
members for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to underwriters and selling 
group members that may make Internet distributions on the same basis as other allocations. 
Lock-up 
We will agree that we will not, subject to certain exceptions. (I) offer, pledge, announce the intention to sell, sell, contract to sell, sell any 
option or contract to purchase, purchase any option or contract to sell, grant any option. right or warrant to purchase, or otherwise transfer or 
dispose of, directly or indirectly, or file with the SEC a registration statement under the Securities Act relating to, any shares of our common stock 
or securities convertible into or exchangeable or exercisable for any shares of our common stock. or publicly disclose the intention to make any 
offer, sale, pledge. disposition or filing, or (2) enter into any swap or other arrangement that transfers all or a portion of the economic consequences 
associated with the ownership of any shares of common stock or any such other securities (regardless of whether any of these transactions are to be 
settled by the delivery of shares of common stock or such other securities, in cash or otherwise), in each case without the prior written consent of 
J.P. Morgan Securities LI.0 and Citigroup Global Markets Inc. for a period of 180 days after the date of this prospectus, other than the shares of 
our common stock to be sold or isard hereunder and any shares of our common stock issued upon the exercise of options granted under our 
existing equity incentive plans. 
Our executive officers, directors and all our existing stockholders, including the selling stockholders, will enter into lock-up agreements 
with the underwriters prior to the commencement of this offering pursuant to which each of these persons or entities, for a period of 180 days after 
the date of this prospectus. may not, without the prior written consent of J.P. Morgan Securities LI.0 and Citigroup Global Markets Inc., subject to 
certain exceptions. (I) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option 
or contract to sell, grant any option, right or warrant to purchase, or 
130 
httplAvaw.sec. gov/Archi vatedgar/datat I 609989/000119312515218883/d734898dsl.htm(7/20/2015 10:30:13 AM) 
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) 
CONFIDENTIAL 
DB-SDNY-0080217 
SDNY GM_00226401 
EFTA01381328
